Skip to main content
. 2021 Sep 25;22:101596. doi: 10.1016/j.jcot.2021.101596

Table 5.

Miscellaneous outcomes.

Authors & Year Classification Evidence Level No. of Patients Age (yrs) ∗ Surgery Type Tumor Histology Complications (no.) or % Outcomes
Chong-chung
et al., 2018
Retrospective study 3 65 57.26 A total of 29 (44.62%)
patients had the Luque
rods and sublaminar wire
system, 24 (36.92%) pat-
ients had posterior screws
and rods system, 9 (13.85
%) patients had an anterior
cage and plate applied, and
3 (4.62%) had the
combined anterior &
posterior system.
17 (26.15%) patients suff-
ered from lung primary,
while 16 (24.62%) patients
suffered from breast prim-
ary. Other malignant origins
included colorectal, thyroid,
prostate, renal cell carcin-
oma, nasopharyngeal car-
cinoma, hepatocellular
carcinoma, germ cell tum-
our, multiple myeloma,
bladder carcinoma, hypo-
pharynx carcinoma and
soft tissue sarcoma.
This paper focused on
loostening rate and consequences of
this. The overall loosening rate of imp-
lants was 44.4%. This was particularly
high in the group with Luque rods and
sublaminar wire system (70%) and the
posterior screws and rod system (50%).
Survival ranged from 1 month to 92
months, with a mean survival of 13.5
months. 40 (61.54%) of the 65 cases
survived for at least 1 year after the
operation. 27 (67.5%) of them had
imaging after 1 year postoperatively,
mean survival here of 27.63 months;
the remaining 13 patients had no
available imaging after 1 year post-
operatively, here the mean survival
was 23 months.
Walter et al.
2012
Retrospective study 3 57 58.6 All patient were operated
in the prone position. For
posterolateral decomp-
ression, laminectomy is
performed and bilateral
removal of the pedicles
and facets to achieve
circumferential decomp-
ression and facilitate post-
erolateral tumour excision.
To improve seeing the
thoracic spine, the medial
rib head is excised, if
needed. After
adequate decompression,
the operated vertebrae are
stabilized, using the UniFlex screw rod system.
Plasmocytoma 10 (17.6%),
breast 8 (14.0%), lung 7
(12.4%), renal 6 (10.6%),
prostate 5 (8.8%), CUP-
syndrome 4 (7.0%), colon
3 (5.3%), cervix 3 (5.3%),
bladder 2 (3.5%), NHL 2
(3.5%) and 1 (1.7%) each
for chordoma, ovary,
pancreas, sarcoma,
stomach, testis, undiffer-
entiated carcinoma.
The complication rate was only 5.3% with
2 superficial wound infections along
with 1 seroma likely secondary to
previously received radiotherapy. One
patient required repeat operation for
second-level decompression and stab-
ilization because of a massive local
tumor recurrence. No intraoperative
death occurred, but 3 (5.3%) patients
died within 4 weeks of surgery, secondary
to rapid progression of the primary
metastatic disease. No case of posterior
spinal instrumentation fatigue failure
was detected.
The mean postoperative survival of all
57 patients was 11.4 months and ranged from 0 to 46
months. The 1-year survival rate was 42.1%.
There being a tendency toward improved Frankel grades
after the operation. 13 (22.8%) patients showed an
improvement of their neurological deficits, 43 (75.5%)
had a stable neurological status, and only one single
patient (1.8%) suffered from deterioration of neurological
status.